Rate My Professor Chris Frampton

Frampton has co-authored an extensive array of peer-reviewed publications, demonstrating significant contributions to diverse medical domains. Key works include 'Predictors of rural medical practice in Aotearoa New Zealand' (2026), 'Timing of antibacterial prophylaxis and surgical site infection rates' (2025), 'Compulsory Community Treatment Orders and health outcomes for people with schizophrenia spectrum disorders' (2024), 'A self-guided virtual reality solution for social anxiety' (2024), 'Clinical features and mortality outcomes of people transferred from emergency departments to inpatient mental health units' (2025), 'Development and Investigation of a Non-invasive Disease Severity Index for Crohn's Disease' (2024), 'Air Travel Hypoxemia vs the Hypoxia Inhalation Test' (2008), and 'Metabolic risk factors in a New Zealand glioblastoma cohort' (2022). He serves on the Scientific Assessment Committee of the Canterbury Medical Research Foundation, evaluating research proposals. Through his methodological contributions, Frampton has bolstered the analytical foundation of numerous studies at the University of Otago and collaborating institutions, enhancing research quality in psychiatry, cardiology, internal medicine, and related fields.